- Home
- WIX vs XENE Comparison
WIX vs XENE Comparison
Compare WIX & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WIX | XENE |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | Israel | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.7B |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WIX | XENE |
|---|---|---|
| Price | $73.69 | $37.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 19 |
| Target Price | ★ $79.65 | $74.31 |
| AVG Volume (30 Days) | 1.0M | ★ 2.5M |
| Earning Date | 11-18-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $311,000.00 |
| Revenue This Year | $13.31 | N/A |
| Revenue Next Year | $10.79 | $2,045.70 |
| P/E Ratio | $28.86 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $40.00 | $36.07 |
| 52 Week High | $148.33 | $72.66 |
Technical Indicators
Market Signals| Indicator | WIX | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 46.94 | 23.64 |
| Support Level | $69.27 | N/A |
| Resistance Level | $83.37 | $45.18 |
| Average True Range (ATR) | 4.53 | 1.94 |
| MACD | -1.16 | -0.53 |
| Stochastic Oscillator | 35.92 | 6.25 |
Price Performance
Historical ComparisonAbout WIX Wix.com Ltd.
Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years, it has invested heavily and introduced its Wix Studio offering for partners, which are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.